Navigation Links
Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference
Date:1/11/2008

REDWOOD CITY, Calif., Jan. 11 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company focused on the development of improved protein drugs, today announced that it will present at the Stanford Group Company 13th Annual Healthcare Conference on Thursday, January 17, 2008 at 7:45 a.m. Eastern Time. Russell Howard, Maxygen's chief executive officer, will present. A live webcast of the presentation can be accessed on Maxygen's website at http://www.maxygen.com/webcasts. A replay of the presentation will be available for 90 days.

About Maxygen

Maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs. We look for opportunities where our proprietary protein modification technologies can address significant therapeutic needs. Our lead program, MAXY-G34, is designed to be an improved version of G-CSF for the treatment of neutropenia. MAXY-G34 is currently in Phase II clinical trials. Also in our pipeline is a novel Factor VIIa for the treatment of hemophilia. Maxygen's approach to drug discovery and development may allow us to leverage the established development and regulatory paths of approved drugs. We believe this advantage translates to a greater chance of successfully bringing important new drugs to market. http://www.maxygen.com


'/>"/>
SOURCE Maxygen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Maxygen to Present at the JPMorgan 26th Annual Healthcare Conference
2. Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
3. Maxygen Reports Third Quarter 2007 Financial Results
4. Maxygen Announces Upcoming Webcasts at Investor Conferences
5. Maxygen Third Quarter 2007 Financial Results Conference Call Notice
6. Maxygen Announces Hold on MAXY-alpha Development Program
7. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference Today
8. Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
11. ARCA Discovery, Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... to biotechnology firms has revealed early bottlenecks on ... the researchers suggest that better communication of basic ... to faster commercialization down the road. , Biopharmaceutical ... university laboratories and licensed to biotechnology firms. Bottlenecks ... a high failure rate. But a new study ...
(Date:8/20/2014)... Aug. 20, 2014  Decision Resources Group finds that the vascular ... Russia , India and ... 2013, roughly equal to the size of the United ... market will experience much faster growth as a result of strong ... Other key findings from Decision Resources Group,s coverage of the ...
(Date:8/20/2014)... in your ear could improve the health of your ... University of Leeds used a standard TENS machine like ... pulses to the tragus, the small raised flap at ... the ear canal. , The stimulation changed the influence ... the nervous signals that can drive failing hearts too ...
(Date:8/19/2014)... DUBLIN , Aug. 19, 2014 Research and ... Culture Supplies - Global Strategic Business Report" report to their ... Cell and Tissue Culture Supplies in US$ Thousands by the following ... separate comprehensive analytics for the US, Canada , ... Asia-Pacific , and Latin America . ...
Breaking Biology Technology:Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3'Tickling' your ear could be good for your heart 2Global Cell and Tissue Culture Supplies - Strategic Business Report 2014 2
... - For Effective ... EMBASE(R), Elsevier,s biomedical and pharmaceutical ... with QUOSA(TM) to enable,mutual customers to download and manage ... established EMBASE.com channel in QUOSA Information,Manager. , ...
... WAYNE, Pa., Nov. 28 Encorium Group, Inc.,(Nasdaq: ... organization,(CRO) conducting studies in over 30 countries for many ... that on November,21, 2008, it received a letter from ... 10-Q for the quarterly period ended September 30, 2008 ...
... SAN DIMAS, Calif., Nov. 28 Why Humans ... Bill Sardi, co-founder and formulator of Longevinex(R) (long-jev-in-ex), a nutriceutical product ... To view the Multimedia News Release, go to: , ... The film presents the " overmineralization " theory of aging ...
Cached Biology Technology:Elsevier's EMBASE.com Partners With QUOSA 2Elsevier's EMBASE.com Partners With QUOSA 3Elsevier's EMBASE.com Partners With QUOSA 4Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing 2Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing 3Video: 8-Minute Film Documentary Explores Why Humans Age 2
(Date:8/20/2014)... Health has awarded the Oklahoma Medical Research Foundation a ... anthrax and the bacteria,s effects on humans. , ... his colleagues have studied the human immune response to ... Human Immunology. The original funding came soon after anthrax-laced ... of the terrorist attacks of Sept. 11, 2001. ...
(Date:8/20/2014)... the past few years, Virginia Tech,s Wu Feng has ... grant from the "Computing in the Cloud" program, and ... $6 million award from the Air Force on "big ... NSF and the National Institutes of Health on "big ... together the "parallel computing" aspects from each grant, he ...
(Date:8/20/2014)... Carolina State University researchers have developed methods for electronically ... the electrical signals moths use to control those muscles. ... remotely-controlled moths, or "biobots," for use in emergency response. ... whether we can control the movement of moths for ... says Dr. Alper Bozkurt, an assistant professor of electrical ...
Breaking Biology News(10 mins):$14.5 million grant awarded to continue anthrax studies 2The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4Research paves way for development of cyborg moth 'biobots' 2
... EAST LANSING, Mich. -- Time marches on, ... of wildlife habitat now can monitor changes over ... and projecting future changes are essential for sustainable ... wildlife habitat," said Jianguo "Jack" Liu, Rachel Carson ...
... in The FASEB Journal ( http://www.faseb.org ) suggests that pregnant ... babies who are likely to become junk food junkies themselves. ... the high fat and high sugar diet leads to changes ... only does this offer insight into the ever-increasing rate of ...
... 23, 2011 -- Structural studies of some of ... way for new generations of biologically inspired solar ... St. Louis and the Department of Energy,s Oak ... analyze the structure of chlorosomes in green photosynthetic ...
Cached Biology News:'Junk food' moms have 'junk food' babies 2Neutron analysis yields insight into bacteria for solar energy 2
Mouse polyclonal antibody to PRDM2 - PR domain containing 2, with ZNF domain...
Anti Human S14G-Humanin Polyclonal Antibody...
... familiar interface for data capture, recording, ... transition from paper to this powerful ... contains an integrated LIMS, notary service, ... These functions allow LABTrack to achieve ...
High voltage electrophoresis power supply...
Biology Products: